Company Filing History:
Years Active: 1996-2002
Title: The Innovations of Hans-Otto Werling
Introduction
Hans-Otto Werling is a notable inventor based in Wuppertal, Germany. He has made significant contributions to the field of pharmaceuticals, particularly in the treatment of infections and associated gastroduodenal diseases. With a total of 10 patents to his name, his work has had a considerable impact on medical science.
Latest Patents
Werling's latest patents include the use of 7-(2-oxa-5,8-diazabicyclo[4.3.0]non-8-yl)-quinolone carboxylic acid and naphthyridone carboxylic acid derivatives for the treatment of Helicobacter pylori infections and associated gastroduodenal diseases. This invention focuses on quinolone- and naphthyridone carboxylic acid derivatives that are substituted in the 7-position by a specific radical, along with their pharmaceutically utilizable hydrates and/or salts. Another significant patent involves the use of 7-(1-aminomethyl-2-oxa-7-aza-bicyclo[3.3.0]oct-7-yl)-quinolone carboxylic acid and naphthyridone carboxylic acid derivatives for treating similar infections and disorders.
Career Highlights
Throughout his career, Werling has worked with prominent companies such as Bayer Aktiengesellschaft and Bayer Intellectual Property GmbH. His experience in these organizations has allowed him to develop and refine his innovative ideas, contributing to advancements in pharmaceutical research.
Collaborations
Werling has collaborated with notable colleagues, including Klaus Schaller and Harald Labischinski. These partnerships have fostered a collaborative environment that has led to the successful development of his patented inventions.
Conclusion
Hans-Otto Werling's contributions to the field of pharmaceuticals through his innovative patents demonstrate his commitment to advancing medical science. His work continues to influence the treatment of infections and related diseases, showcasing the importance of innovation in healthcare.